Bank of America
BAC
$51.23
-0.91%
Bank of America Corporation is one of the largest diversified financial institutions in the United States, operating a roughly $3.5 trillion balance sheet across four core segments: consumer banking, global wealth and investment management, global banking, and global markets. The firm holds the second-largest U.S. deposit market share, a top-four global investment banking franchise, and the fourth-largest global trading operation, giving it a scale-driven, fee-diversified identity that straddles Main Street retail banking and Wall Street capital markets. The current investor narrative is dominated by the tension between a strong core franchise and a disappointing third-quarter print — the stock plunged on October 14 after an earnings miss compounded by a regulatory fine, even as management raised 2027 net interest income guidance and highlighted a durable deposit base. Bulls point to a 14% dividend increase, aggressive buybacks, and a cheap multiple as evidence the sell-off is overdone, while bears flag sticky 3.7% inflation, revived Fed hike risk, rising deposit costs, and a lagging investment banking recovery relative to advisory-heavy peers like Jefferies and Morgan Stanley.…
BAC
Bank of America
$51.23
Related headlines
Investment Opinion: Should I buy BAC Today?
Rating: Buy. The core thesis is that BAC's sell-off is overdone relative to its fundamental earnings power, with the stock trading at 9.86x forward earnings and every analyst target above the current price. The consensus rating is 'strong buy' (mean 1.48) with an average target of $63.45, implying 23.9% upside, and even the lowest target of $56.00 offers 9.3% upside. This unanimity suggests the market has decoupled from analyst expectations.
Supporting evidence includes revenue growth of 5.84% year-over-year to $49.393 billion in Q2 2026, with net income up 20.5% to $9.074 billion and net margin expanding to 18.37% from 15.15% in Q4 2025. Gross margin improved to 61.13% from 53.30% a year earlier, and operating margin rose to 23.41% from 16.47%. Free cash flow is robust at $94.742 billion TTM, comfortably funding $6.0 billion of buybacks and $2.33 billion of dividends in Q2 alone. The 2.36% dividend yield and 31.34% payout ratio are well-covered, and the 14% dividend raise underscores management's confidence. The PEG ratio of 0.73 and forward PE of 9.86x compare favorably to the broader market and suggest the stock is undervalued relative to its growth prospects.
Key risks that could invalidate the thesis include a renewed Fed hiking cycle that spikes deposit costs and compresses NII, a failure of the investment banking recovery to broaden beyond advisory-heavy peers, and a recession that drives credit losses. The rating would upgrade to a stronger Buy if the stock pulls back to the 52-week low of $46.12 (implying a forward PE of 6.8x) or if Q3 earnings show NII stabilization and IB fee acceleration. It would downgrade to Hold if revenue growth decelerates below 3% or if net margin falls below 15%. Relative to its own history (PE range 7.5x-23.4x) and peers, BAC at 14.18x trailing PE is fairly valued, but the 9.86x forward PE is undervalued if consensus estimates hold.
Sign up to view all
BAC 12-Month Price Forecast
The forward-looking view is bullish, primarily because the stock's valuation already discounts significant headwinds. At 9.86x forward earnings, BAC is priced for a recession that may not materialize, while the analyst community unanimously sees upside to $63.45. The improving margin trend and robust free cash flow support the dividend and buyback, providing a floor for the stock. However, the technical breakdown and recent earnings miss warrant caution, hence medium confidence. An upgrade to high confidence would require Q3 earnings showing NII stabilization and IB fee growth; a downgrade to neutral would follow a break below the 52-week low of $46.12 or a further deterioration in net interest margin.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bank of America's 12-month outlook, with a consensus price target around $63.45 and implied upside of +23.9% versus the current price.
Average Target
$63.45
0 analysts
Implied Upside
+23.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$56 - $71
Analyst target range
Coverage is deep and overwhelmingly constructive, with 22 analysts and a consensus recommendation of "strong buy" (mean rating 1.48 on a 1-5 scale). The average target price of $63.45 implies +23.9% upside from the current $51.23, and even the lowest target of $56.00 sits +9.3% above the current price — meaning every published analyst target is above the market, a rare unanimity that signals the sell-off has decoupled from fundamental expectations. The consensus leans decisively bullish, supported by a steady stream of reiterated Overweight and Buy ratings from UBS, JPMorgan, Wells Fargo, Barclays, RBC, and Truist through July and August 2026, with no downgrades in the institutional ratings data. The target range of $56.00 to $71.00 spans roughly 27% of the current price, a moderately wide spread that reflects uncertainty over the pace of NII recovery and capital markets normalization. The high target of $71.00 (about +38.6% upside) likely assumes multiple expansion toward 1.5x book alongside the raised 2027 NII guidance and a rebound in investment banking fees, while the low target of $56.00 (+9.3%) prices in margin compression from rising deposit costs and continued regulatory overhang. The absence of any Sell ratings and the clustering of targets in the $60-65 range suggest strong conviction in the franchise, though the recent earnings miss and regulatory fine are a reminder that execution risk remains — the gap between the $63.45 consensus and the $51.23 market price is the central debate for investors.
Drowning in data?
Find the real signal!
Bulls vs Bears: BAC Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a clear downtrend, down 16.39% over three months with a -20.37% YTD relative strength gap, and the October 14 earnings miss plus regulatory fine triggered heavy institutional selling. However, the bull case rests on compelling valuation and unanimous analyst support—a forward PE of 9.86x and an average target of $63.45 imply 23.9% upside. The single most important tension is whether the raised 2027 NII guidance and improving margin trend (gross margin up to 61.13%) can overcome rising deposit costs and a lagging IB recovery. Resolution of this debate will determine whether the stock re-rates toward book value or tests its 52-week low.
Bullish
- Unanimous analyst targets above price: All 22 analysts covering BAC have targets above the current $51.23, with a low of $56.00 (+9.3%) and an average of $63.45 (+23.9%). The consensus rating is 'strong buy' (mean 1.48), and no downgrades appear in the recent ratings data, suggesting the sell-off has decoupled from fundamental expectations.
- Forward PE of 9.86x implies deep value: Based on consensus EPS of $6.82, BAC trades at just 9.86x forward earnings, a single-digit multiple that historically has marked attractive entry points for money-center banks. The PEG ratio of 0.73 further supports the view that growth is not being priced in.
- Improving profitability and margins: Q2 2026 net income rose to $9.074 billion with an 18.37% net margin, up from $7.528 billion and 15.15% in Q4 2025. Gross margin expanded to 61.13% from 53.30% a year earlier, and operating margin improved to 23.41% from 16.47% in Q2 2025.
- Strong capital return and dividend growth: BAC raised its dividend by 14% and has a 13-year track record of dividend growth, with a well-covered 31.34% payout ratio and 2.36% yield. In Q2 2026 alone, operating cash flow of $29.0 billion comfortably funded $6.0 billion of buybacks and $2.33 billion of dividends.
Bearish
- Severe technical breakdown and underperformance: BAC is down 11.52% over the past month and 16.39% over three months, versus the S&P 500's +1.22% and +2.69%, respectively. The stock sits just 26.8% of the way up its 52-week range and has a max drawdown of -20.95%, indicating entrenched negative momentum.
- Earnings miss and regulatory fine: The October 14 earnings miss, compounded by a regulatory fine, triggered a plunge from $53.96 to $51.39 on elevated volume of 64.3 million shares. This confirms institutional distribution and raises questions about execution and compliance risk.
- Lagging investment banking recovery: While advisory-heavy peers like Jefferies and Morgan Stanley are capturing the IB recovery, BAC's universal bank model is lagging. This mix issue means the bank is not fully capitalizing on the capital markets rebound, limiting fee growth.
- Sticky inflation and deposit cost pressure: 3.7% inflation has revived Fed hike risk, which could pressure margins via rising deposit costs. The current ratio of 0.417 and total-debt-to-capitalization of 70.86% reflect the bank's sensitivity to rate-driven funding costs and mark-to-market risk on its $57.99 billion of Q2 investment securities purchases.
BAC Technical Analysis
Bank of America is in a clear intermediate downtrend despite a marginally positive one-year return of +1.57%, with the stock now trading at $51.23 — just 26.8% of the way up its 52-week range of $46.12 to $65.23. That positioning near the lower quartile of the annual band signals deteriorating momentum rather than a value floor, and the -20.95% max drawdown confirms the stock has already surrendered more than a fifth of its peak value. The year-to-date decline of -8.44% versus the S&P 500's +11.93% leaves BAC with a -20.37% relative strength gap, an unambiguous signal of sustained underperformance against the broader market. Recent momentum has been sharply negative and accelerating: the stock is down -11.52% over the past month and -16.39% over three months, a stark reversal from the +1.57% twelve-month figure and a divergence that points to trend deterioration rather than a temporary pullback. The one-month relative strength of -12.74% against SPY's +1.22% shows the underperformance is widening, and the October 14 earnings-driven plunge from $53.96 to $51.39 on elevated volume (64.3 million shares) confirms institutional distribution. The 3-month change of -16.39% versus the 6-month change of -4.97% indicates the selling pressure has intensified in the most recent quarter, a classic pattern of momentum breakdown. Key technical support sits at the 52-week low of $46.12, roughly 10% below the current $51.23; a breakdown there would likely trigger further systematic selling and open a deeper retracement. Resistance is anchored at the 52-week high of $65.23, about 27% above current levels, with intermediate resistance near the $56-57 area where the September breakdown began. With a beta of 1.214, BAC is roughly 21% more volatile than the market, meaning position sizing should account for amplified drawdowns in risk-off regimes — a 10% market decline could translate to roughly a 12% hit here.
Beta
1.21
1.21x market volatility
Max Drawdown
-20.9%
Largest decline past year
52-Week Range
$46-$65
Price range past year
Annual Return
+1.6%
Cumulative gain past year
| Period | BAC Return | S&P 500 |
|---|---|---|
| 1m | -11.5% | +0.2% |
| 3m | -16.4% | +2.9% |
| 6m | -5.0% | +8.4% |
| 1y | +1.6% | +14.9% |
| ytd | -8.4% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAC Fundamental Analysis
Revenue is growing at a healthy clip, with Q2 2026 revenue of $49.393 billion up 5.84% year-over-year from $46.666 billion in Q2 2025, and the multi-quarter trajectory shows steady sequential expansion from $47.886 billion in Q1 2026 and $49.691 billion in Q4 2025. Segment data reveals a balanced franchise: Global Markets at $7.109 billion and Consumer Banking at $11.049 billion lead, followed by Global Wealth and Investment Management at $6.712 billion and Global Banking at $6.287 billion, with the markets and wealth businesses providing fee-based diversification against rate-sensitive lending. The growth trend supports the investment case for durable earnings power, though the recent earnings miss and lagging investment banking recovery suggest the mix is not firing on all cylinders. Profitability is solid and improving: Q2 2026 net income reached $9.074 billion with a net margin of 18.37%, up from $8.584 billion and 17.93% in Q1 2026 and $7.528 billion and 15.15% in Q4 2025, while gross margin expanded to 61.13% from 60.42% sequentially and 53.30% a year earlier. The operating margin of 23.41% in Q2 2026 compares favorably to 21.73% in Q1 and 16.47% in Q2 2025, and the trailing twelve-month net margin of 15.93% with a 19.68% operating margin reflects a bank that has moved past the 2024 trough. ROE of 10.06% is respectable but below the 12-13% levels BAC targets, leaving room for improvement as capital markets activity normalizes. Balance sheet leverage is typical for a money-center bank but warrants monitoring: debt-to-equity stands at 1.21x with a total-debt-to-capitalization ratio of 70.86%, and the current ratio of 0.417 reflects the deposit-funded liability structure inherent to banking rather than a liquidity stress signal. Free cash flow is robust at $94.742 billion TTM, and Q2 2026 operating cash flow of $29.043 billion comfortably funded $6.006 billion of buybacks and $2.33 billion of dividends, demonstrating internal capital generation. The payout ratio of 31.34% and 2.36% dividend yield are well-covered, and the 13-year dividend growth track record with a recent 14% raise underscores capital return commitment, though the $229.745 billion cash position and heavy investment securities purchases ($57.99 billion in Q2) show the bank remains sensitive to rate-driven mark-to-market risk.
Quarterly Revenue
$49.4B
2026-06
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
61.1%
Latest Quarter
Free Cash Flow
$94.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAC Overvalued?
Because Bank of America is solidly profitable with trailing EPS of $3.61 (implied by the $51.23 price and 14.18x trailing PE), the PE ratio is the appropriate primary metric rather than PS or EV/Sales. The trailing PE of 14.18x against a forward PE of 9.86x implies the market expects earnings to grow roughly 44% over the next twelve months, consistent with consensus EPS of $6.82 versus the current run-rate — a gap that reflects either optimistic normalization of capital markets and NII or a market that is discounting near-term headwinds. The PEG ratio of 0.73 suggests the stock is cheap relative to its expected growth, a classic value signal if the earnings estimates hold. Against the broader financial services sector, BAC's 14.18x trailing PE and 1.34x price-to-book sit at a modest premium to book but a discount to the market multiple, and the 2.11x PS ratio is reasonable for a bank with a 15.93% net margin. The 1.34x P/B versus a historical range that has spanned 0.76x (Q3 2023) to 1.36x (Q2 2026) places the stock near the top of its own book-value band, suggesting the market is pricing in improved returns rather than distress. Historically, BAC's PE has ranged from roughly 7.5x in mid-2023 to 23.4x in Q4 2023, with the current 14.18x sitting in the middle of that band — neither a screaming bargain nor an overextended multiple. The forward PE of 9.86x is the more compelling data point: if consensus EPS of $6.82 materializes, the stock trades at single-digit earnings, which historically has marked attractive entry points for money-center banks.
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin pressure from rising deposit costs and the bank's sensitivity to rate-driven mark-to-market losses. With a total-debt-to-capitalization ratio of 70.86% and $57.99 billion of investment securities purchased in Q2 2026, BAC carries meaningful exposure to interest rate fluctuations. The 3.7% inflation reading revives Fed hike risk, which could compress net interest margin as deposit costs reprice higher. Additionally, the recent earnings miss and regulatory fine highlight execution and compliance risks that could recur, while the lagging investment banking recovery means fee income is not fully offsetting lending margin pressure. ROE of 10.06% remains below the 12-13% target, leaving less cushion if conditions deteriorate.
Market and competitive risks include valuation compression if the stock's premium to book (1.34x P/B) unwinds toward its historical low of 0.76x. BAC's beta of 1.214 means it is roughly 21% more volatile than the market, so a 10% market decline could translate to a 12% hit. The stock has already underperformed the S&P 500 by 20.37% YTD, and sector rotation away from banks could exacerbate outflows. Competitive disruption from advisory-heavy firms like Jefferies and Morgan Stanley in investment banking, plus fintech encroachment in consumer banking, threatens market share. Regulatory headwinds, including the recent fine, remain an overhang.
The worst-case scenario would combine a renewed Fed hiking cycle that spikes deposit costs, a recession that drives credit losses, and a failed rebound in capital markets. In that chain, BAC could retest its 52-week low of $46.12, representing a 10.0% decline from the current $51.23. A more severe outcome, such as a systemic risk-off event, could push the stock toward its historical low P/B of 0.76x, implying a price near $29 (based on book value per share of roughly $38.4), a 43% downside. The analyst low target of $56.00 is above the current price, so the realistic bear case is a drop to the 52-week low, or -10%, with tail risk to the high-$20s if book value is re-rated to crisis levels.
FAQ
The most severe risk is margin compression from rising deposit costs if the Fed hikes rates further due to 3.7% inflation, which could pressure NII and earnings. Second is credit risk from a recession, which would drive loan losses and require higher provisions. Third is regulatory risk, highlighted by the recent fine, which could lead to higher compliance costs or capital requirements. Fourth is competitive risk in investment banking, where BAC is lagging advisory-heavy peers like Jefferies and Morgan Stanley, limiting fee growth. These risks are ranked by severity, with margin compression being the most immediate.
The 12-month forecast has three scenarios: a base case (55% probability) targeting $56-$65, aligned with the analyst average of $63.45; a bull case (25%) targeting $65-$71, assuming a soft landing and capital markets rebound; and a bear case (20%) targeting $46-$56, assuming a recession and retest of the 52-week low. The most likely scenario is the base case, where EPS grows toward $6.82 and the stock re-rates modestly. The key assumption is that NII stabilizes and the investment banking recovery broadens.
BAC appears undervalued on forward earnings: the forward PE of 9.86x is well below the trailing PE of 14.18x and the market multiple, implying the market expects 44% EPS growth. The PEG ratio of 0.73 suggests the stock is cheap relative to its growth. However, on a price-to-book basis, 1.34x is near the top of its historical range (0.76x-1.36x), so the market is not pricing in distress. Relative to peers, BAC's 14.18x trailing PE is in line with money-center banks. The valuation implies the market expects a slowdown, but if consensus EPS of $6.82 materializes, the stock is undervalued.
From a risk/reward perspective, BAC offers a favorable setup: the average analyst target of $63.45 implies 23.9% upside, and even the lowest target of $56.00 is 9.3% above the current price. The forward PE of 9.86x is low for a franchise with a 15.93% net margin and a 2.36% dividend yield. However, the biggest downside risk is a retest of the 52-week low of $46.12, or -10%, if inflation forces further Fed hikes. For long-term investors with a 2-3 year horizon, the stock is a good buy at current levels, but short-term traders should wait for technical stabilization above the $50 support.
BAC is better suited for long-term investment given its beta of 1.214, which implies above-market volatility, and its current technical downtrend. The stock's 2.36% dividend yield and 13-year dividend growth track record provide income, but the recent -20.95% max drawdown shows short-term risk. Earnings visibility is moderate, with consensus EPS of $6.82 for the next twelve months. A suggested minimum holding period is 2-3 years to allow for the capital markets cycle to normalize and for the valuation gap to close. Short-term traders could trade the range between $46 and $56, but timing the bottom is difficult.
